Streetbeat News

Assets

BEEP

Mobile Infrastructure reported a significant Q3 2023 net loss of $23.1 million, or $1.77 per diluted share, compared to a net loss of $2.9 million, or $0.22 per diluted share, in the same period last year. Sales decreased to $8.06 million from $8.35 million. The loss was largely due to non-recurring charges related to a merger and repositioning, including a $16.1 million non-cash charge for Series 2 Preferred Stock and $8.7 million impairment charges for three parking facilities. Adjusted EBITDA increased by 2.3% to $4.4 million. The company's total debt decreased to $193.5 million from $219.7 million at the end of 2022, with a weighted-average interest rate of 6.8%.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:54 am

OCN

Z

ZG

PHH Mortgage, a subsidiary of Ocwen Financial Corporation (NYSE:OCN), has entered into a mortgage subservicing agreement with Zillow Home Loans, expanding their existing relationship. The initial onboarding of loans was completed in August 2023. This partnership aligns with PHH's strategy to grow its subservicing portfolio and reinforces its position as a leading subservicer. PHH has been recognized for servicing excellence by Freddie Mac, Fannie Mae, and HUD, highlighting its industry standing.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:42 pm

NMRD

Nemaura Medical announced that as of September 30, 2023, it had approximately $4.4 million in cash and cash equivalents.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:40 pm

THRX

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) announced a significant workforce reduction of approximately 72% as part of a strategic process to maximize shareholder value. This process may include the sale of company assets, a sale of the company, a merger, or other strategic actions. Despite the reduction, the company reported having $225.4 million in cash, cash equivalents, and marketable securities as of September 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:33 pm

NBTX

NANOBIOTIX reported its cash and cash equivalents as €38.7 million as of September 30, 2023. This financial update provides investors with insight into the company's liquidity and financial health at the end of the third quarter.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:31 pm

RZLT

Rezolute, Inc. reported a net loss of $14.5 million for Q1. As of September 30, the company had a total of $106.9 million in cash, cash equivalents, and investments in marketable debt securities.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:29 pm

BITW

BLOK

GBTC

Crypto fund inflows have surpassed $1 billion in 2023, with Bitcoin, Ethereum, and Solana leading the charge. CoinShares reports a seven-week inflow streak, adding $293 million recently. Bitcoin investment products saw $240 million inflows, Ethereum had its highest inflows since August 2022 at $49.1 million, and Solana received $12.4 million. The upcoming Benzinga’s Future Of Digital Assets Event will discuss the potential impact of a Bitcoin ETF approval. Total assets under management are at their highest since May 2022, with a 9.6% increase over the past week and a 99% rise since the start of the year. Bitcoin ETPs and blockchain equity ETFs also saw significant inflows. Regionally, Canada leads in inflows, followed by the U.S., Germany, and Switzerland. Bitcoin's price was up 5%, Ethereum saw a 10% increase, and Solana led with a 33% gain over the past week.

Portfolio Pulse from Khyathi Dalal

November 13, 2023 | 10:29 pm

NERD

Roundhill Investments has announced that it will transfer the listing of its Roundhill Video Games ETF (NERD) from NYSE Arca to Nasdaq. This move is part of a strategic decision to benefit from Nasdaq's trading platform and visibility.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:26 pm

NRBO

NeuroBo Pharmaceuticals reported having cash and cash equivalents of $25.8 million as of September 30.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:26 pm

ATXI

Avenue Therapeutics reported a cash position of $200,000 as of September 30. This financial update is crucial for investors monitoring the company's liquidity and financial stability.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:16 pm